2026 Q2 Portfolio Activity
In 2026 Q2, Foresite Capital Management IV, LLC maintained a portfolio of 9 distinct positions. The most significant new addition was Crinetics Pharmaceuticals, Inc, now representing 1.93% of the total fund value. They heavily accumulated shares in CYTOKINETICS INC, increasing the position by 42.0%. Conversely, Foresite Capital Management IV, LLC completely exited their position in Lyell Immunopharma, Inc..
Position History
hover any row below to update
Loading…
Total Positions
9
Quarter
2026 Q2
Top Holding
PHVS (57.0%)
Top 10 Concentration
100.0%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
Showing 1-9 of 9
Foresite Capital Management IV, LLC Full Holdings List — 2026 Q2
| Stock | History | Sector / Type | Port % | Prev % | Rank / Prev | Conviction | Change | % Change | Influence | Shares | Mkt Value | Avg Cost | Price Held | 1st Owned | Source | Source Date | Date Reported | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
PHVS
Pharvaris N.V.
|
Healthcare | 56.95% | 56.94% |
#1
Prev: #1
|
7.0 |
—
|
no change | no change |
P
S
|
4,778,581 | $165,243,331 | 2021 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
CYTK
CYTOKINETICS IN...
|
Healthcare | 20.98% | 13.99% |
#2
Prev: #2
|
8.0 |
—
|
211,400 | 42.0% |
P
S
|
714,695 | $60,884,867 | 2018 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
N/A
Eikon Therapeut...
|
|
Unknown | 8.74% | 8.67% |
#3
Prev: #3
|
5.5 |
—
|
no change | no change |
P
S
|
1,943,682 | $25,365,050 | — | 13F Filing | 2026-06-30 | 2026-08-14 | ||
|
RLAY
Relay Therapeut...
|
Healthcare | 8.06% | 4.20% |
#4
1
Prev: #5
|
6.2 |
—
|
250,000 | 25.0% |
P
S
|
1,250,000 | $23,387,500 | 2020 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
XENE
Xenon Pharmaceu...
|
Healthcare | 3.33% | 3.92% |
#5
1
Prev: #6
|
2.8 |
—
|
no change | no change |
P
S
|
160,000 | $9,657,600 | 2018 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
CRNX
Crinetics Pharm...
|
Healthcare | 1.93% | — |
#6
Prev: #—
|
4.3 |
—
|
150,000 | — |
NEW
|
150,000 | $5,613,000 | 2018 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
MAZE
Maze Therapeuti...
|
Healthcare | 0.00% | 1.98% |
Sold All 😨
(Was: #8) |
0.0 |
—
|
-156,901 | -100.0% |
CLOSED
|
— | $— | 2025 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
ALEC
Alector, Inc.
|
Healthcare | 0.00% | 3.53% |
Sold All 😨
(Was: #7) |
0.0 |
—
|
-3,887,200 | -100.0% |
CLOSED
|
— | $— | 2019 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
LYEL
Lyell Immunopha...
|
Healthcare | 0.00% | 6.77% |
Sold All 😨
(Was: #4) |
0.0 |
—
|
-800,399 | -100.0% |
CLOSED
|
— | $— | 2021 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 |
Showing 1-9 of 9 holdings